In an adult with a urinary tract infection caused by Staphylococcus epidermidis (susceptible to nitrofurantoin, tetracycline, linezolid, vancomycin; resistant to benzylpenicillin), are levofloxacin (Levaquin) and metronidazole (Flagyl) adequate coverage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Levofloxacin and Metronidazole Are Inadequate for Staphylococcus epidermidis UTI

Levofloxacin and metronidazole will NOT provide adequate coverage for this Staphylococcus epidermidis urinary tract infection. Metronidazole has no activity against staphylococci, and while levofloxacin has some anti-staphylococcal activity, the culture shows superior alternatives that should be used instead 1, 2.

Why This Regimen Fails

Metronidazole Coverage Gap

  • Metronidazole is exclusively an anti-anaerobic agent with activity against Bacteroides fragilis and other obligate anaerobes 3
  • It has zero activity against aerobic gram-positive cocci including all Staphylococcus species 3
  • Metronidazole is recommended only for intra-abdominal infections requiring anaerobic coverage, not for urinary tract infections caused by staphylococci 3, 4

Levofloxacin Limitations

  • While levofloxacin demonstrates activity against S. epidermidis in research studies, with most strains susceptible 2, 5, fluoroquinolone resistance in staphylococci is a significant concern 6, 7
  • Fluoroquinolone resistance rates have reached 98% in MRSA urinary isolates in some populations 6
  • The IDSA guidelines recommend avoiding fluoroquinolones as first-line therapy due to increasing resistance concerns 8

Recommended Treatment Based on Susceptibility Results

Use nitrofurantoin as first-line therapy for this uncomplicated UTI caused by S. epidermidis 1, 6.

Rationale for Nitrofurantoin

  • Your culture shows susceptibility to nitrofurantoin (MIC ≤16 µg/mL) 1
  • Nitrofurantoin demonstrates only 2.7% resistance rates against MRSA urinary isolates 6
  • For catheter-associated UTI, a 7-day course is recommended after catheter removal 1
  • For women aged ≥65 years with CA-UTI without upper tract symptoms after catheter removal, a 3-day regimen may be considered 1

Alternative Options Based on Your Susceptibilities

Linezolid (600 mg PO/IV q12h):

  • Your isolate is susceptible (MIC 1 µg/mL) 9
  • Linezolid shows effectiveness for VRE urinary tract infections despite limited urinary excretion 9
  • Standard duration: 7-14 days for most CA-UTI 1

Tetracycline/Doxycycline:

  • Your isolate is susceptible (MIC ≤1 µg/mL)
  • Reasonable alternative for staphylococcal UTI 10

Vancomycin (if severe illness or bacteremia):

  • Your isolate is susceptible (MIC 4 µg/mL) 10, 6
  • Reserved for systemically ill patients or those requiring IV therapy 6
  • 100% sensitivity demonstrated for MRSA urinary isolates requiring parenteral therapy 6

Critical Clinical Pitfalls to Avoid

Do Not Continue Current Regimen

  • Continuing levofloxacin plus metronidazole wastes the metronidazole component entirely and relies solely on levofloxacin, which is not optimal given available alternatives 3

Assess for Complicated vs. Uncomplicated UTI

  • If this is simple cystitis after catheter removal: use nitrofurantoin 3-7 days 1
  • If patient has delayed response, upper tract involvement, or remains catheterized: extend to 7-14 days 1
  • If patient has pyelonephritis or systemic illness: consider IV vancomycin or linezolid 10, 6

Consider Source Control

  • If catheter remains in place, removal or replacement is essential for treatment success 1
  • Persistent bacteriuria despite appropriate antibiotics suggests need for catheter management 1

References

Research

Activity of levofloxacin and ciprofloxacin against urinary pathogens.

The Journal of antimicrobial chemotherapy, 2001

Research

[Role of levofloxacin in the treatment of urinary tract infections].

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2001

Guideline

Antibiotic Selection and Effectiveness for Common Bacterial Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is levofloxacin appropriate for treating a urinary tract infection caused by Klebsiella pneumoniae and Enterococcus faecalis?
What is the recommended antibiotic for a male patient with a complicated Urinary Tract Infection (UTI) who is on a self-catheterization routine?
What antibiotics are suitable for a patient with a urinary tract infection (UTI) caused by Escherichia coli (E. coli) and a wound infection, who has allergies to Avalox (moxifloxacin) and sulfa drugs, and was initially recommended Levaquin (levofloxacin)?
Is there an interaction between levofloxacin and nitrofurantoin when used concomitantly for treating uncomplicated urinary tract infections?
What is the recommended treatment for an 80-year-old male with a urinary tract infection (UTI) confirmed by urinalysis (UA)?
Why does my migraine persist during a prednisone taper?
What are the recommended step‑by‑step guidelines for safe moderate (conscious) sedation in adults and children older than six months who are American Society of Anesthesiologists (ASA) physical status I‑III?
What is the recommended ceftriaxone dosing for bacterial meningitis in adults, children (including adolescents), and neonates, and how should the regimen be adjusted for renal impairment or when combined with vancomycin or ampicillin?
What are the short‑term and long‑term actions of methylprednisolone?
How many points does a full homonymous hemianopsia score on the NIH Stroke Scale (NIHSS)?
What is the recommended management of cystitis in pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.